Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5)

Vendor: ELK Biotechnology

SKU: EPT084

$399.00 USD
Shipping calculated at checkout.

Documents

Manuals

Available in stock (100)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Biological activity
Immobilized Anti-2019-nCoV S-mIgG1 Antibody (8A5)(Cat#DA035) at 2μg/ml (100 μl/well)can bind 2019-nCoV S Protein RBD-Fc(Cat#DRA126). The ED50 of 2019-nCoV S Protein RBD-Fc(Cat#DRA126) is 5.95 ng/ml.
Delivery condition
The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.
Description
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Storage
24 months from manufacturing at <-20 °C; 1 month, 2 to 8 °C under sterile conditions.
Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5)

Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5)

$399.00 USD